Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects

Conditions:   Idiopathic Pulmonary Fibrosis;   Lung Transplant; Complications Interventions:   Drug: Nintedanib;   Drug: Placebo Oral Tablet Sponsors:   Temple University;   Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials